---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-022711"
form_type: "8-K"
ticker: "AMIX"
cik: "0001617867"
company_name: "Autonomix Medical, Inc."
filed_at: "2024-07-15T23:59:59+00:00"
generated_at: "2026-05-31T20:42:27.921405+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Autonomix licenses FDA-cleared ablation technology; issues 250,000 shares to RF Innovations

## Summary
- Licensed intellectual property for Apex 6 Radiofrequency Generator, an FDA-cleared ablation device for peripheral nerve pain.
- Consideration is 250,000 shares of common stock; license is perpetual, non-exclusive, worldwide, and royalty-free.
- Transaction expected to close before the end of July 2024; manufacturing partner to be integrated into supply chain.
- Technology supports Autonomix's development for pancreatic cancer pain and other indications, potentially simplifying regulatory pathway.

## SEC filing metadata
- accession: 0001437749-24-022711
- form_type: 8-K
- ticker: AMIX
- cik: 0001617867
- company_name: Autonomix Medical, Inc.
- filed_at: 2024-07-15T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1617867/000143774924022711/0001437749-24-022711-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1617867/000143774924022711/amix20240714_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-022711
- JSON: https://secwatch.observer/filing/0001437749-24-022711.json
- Plain text: https://secwatch.observer/filing/0001437749-24-022711.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.